Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

WVE

Wave Life Sciences Ltd.

Dec 08 • 04:00PM ET

4.51

Dollar change -0.28
Percentage change -5.75	%

Healthcare • Biotechnology • Singapore • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.87	Insider Own	26.49%	Shs Outstand	86.92M	Perf Week	-18.24%
Market Cap	446.22M	Forward P/E	-	EPS next Y	-1.00	Insider Trans	-0.14%	Shs Float	72.81M	Perf Month	-21.79%
Income	-85.22M	PEG	-	EPS next Q	-0.23	Inst Own	66.27%	Short Float / Ratio	4.78% / 8.39	Perf Quarter	-4.15%
Sales	85.49M	P/S	5.22	EPS this Y	69.76%	Inst Trans	-0.48%	Short Interest	3.48M	Perf Half Y	10.15%
Book/sh	-0.41	P/B	-	EPS next Y	-60.75%	ROA	-44.69%	Target Price	8.21	Perf Year	12.63%
Cash/sh	1.41	P/C	3.19	EPS next 5Y	-	ROE	-10258.19%	52W Range	3.15 - 7.12	Perf YTD	-35.64%
Dividend	-	P/FCF	-	EPS past 5Y	11.81%	ROI	-	52W High	-36.73%	Beta	-1.19
Dividend %	-	Quick Ratio	1.59	Sales past 5Y	63.94%	Gross Margin	88.87%	52W Low	43.01%	ATR	0.48
Employees	252	Current Ratio	1.59	Sales Q/Q	17168.07%	Oper. Margin	-108.64%	RSI (14)	39.03	Volatility	8.51% 6.51%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	115.74%	Profit Margin	-99.69%	Rel Volume	6.71	Prev Close	4.78
Shortable	Yes	LT Debt/Eq	-	Earnings	Nov 09 BMO	Payout	-	Avg Volume	414.81K	Price	4.51
Recom	2.00	SMA20	-17.26%	SMA50	-18.71%	SMA200	-1.47%	Volume	2,785,095	Change	-5.75%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-05-23	Initiated	Raymond James	Outperform	$7
May-24-23	Downgrade	Jefferies	Buy → Hold	$7 → $5
Dec-15-20	Resumed	H.C. Wainwright	Buy	$20
Oct-23-20	Initiated	RBC Capital Mkts	Sector Perform	$13
Dec-31-19	Downgrade	SVB Leerink	Outperform → Mkt Perform	$33 → $10
Nov-01-19	Initiated	Guggenheim	Buy	$43
Jul-15-19	Initiated	Cowen	Market Perform
Apr-17-19	Reiterated	H.C. Wainwright	Buy	$49 → $33
Aug-07-18	Initiated	Stifel	Buy	$56
Jul-23-18	Initiated	H.C. Wainwright	Buy	$49
Mar-19-18	Reiterated	Mizuho	Buy	$34 → $65
Feb-15-17	Initiated	H.C. Wainwright	Buy	$41
Nov-10-16	Resumed	Leerink Partners	Outperform
Dec-07-15	Initiated	Sun Trust Rbsn Humphrey	Buy	$26
Dec-07-15	Initiated	Leerink Partners	Outperform	$20
Dec-07-15	Initiated	JMP Securities	Mkt Outperform	$52
Dec-07-15	Initiated	Jefferies	Buy	$28

Show Previous Ratings

Dec-07-23 07:00AM	Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares (GlobeNewswire) -30.42%
Dec-06-23 04:10PM	Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +9.22%
04:08PM	Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-Ever RNA Editing Candidate, WVE-006, for Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
Nov-22-23 08:30AM	Wave Life Sciences to Present at 6 Annual Evercore ISI HealthCONx Conference (GlobeNewswire)
Nov-11-23 12:09PM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2023 Earnings Call Transcript (Insider Monkey)
08:38AM	Loading…
Nov-09-23 08:38AM	WAVE Life Sciences Ltd (WVE) Reports Notable Shift to Profitability in Q3 2023 (GuruFocus.com) -9.55%
07:43AM	Wave Life Sciences: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-03-23 04:05PM	Wave Life Sciences Third Quarter 2023 Financial Results Scheduled for November 9, 2023 (GlobeNewswire) +6.02%
Sep-29-23 05:47AM	Wave Life Sciences (WVE) Soars 8.7%: Is Further Upside Left in the Stock? (Zacks)
Sep-28-23 04:15PM	Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annual R&D Day (GlobeNewswire) +8.71%
Sep-25-23 08:30AM	Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-06-23 08:30AM	Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Sep-05-23 07:30AM	Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-006, the First-ever RNA Editing Clinical Candidate, and Plans for Upcoming Virtual R&D Day (GlobeNewswire)
Aug-23-23 11:13AM	WAVE Life Sciences Ltd. Sees a 23% Stock Price Surge Over the Past Three Months (GuruFocus.com) +6.99%
08:44AM	Loading…
Aug-17-23 08:44AM	11 Best Biotech Penny Stocks to Buy Now (Insider Monkey)
06:40AM	7 A-Rated Biotech Stocks for Your August Buy List (InvestorPlace)
Aug-10-23 12:40PM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-08-23 06:02AM	Analyst Forecasts For Wave Life Sciences Ltd. (NASDAQ:WVE) Are Surging Higher (Simply Wall St.)
Aug-04-23 06:45AM	Wave Life Sciences Ltd.'s (NASDAQ:WVE) 42% Price Boost Is Out Of Tune With Revenues (Simply Wall St.)
Aug-03-23 08:55AM	Wave Life Sciences (WVE) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +15.79%
07:53AM	Wave Life Sciences: Q2 Earnings Snapshot (AP Finance)
07:30AM	Wave Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Jul-27-23 08:30AM	Wave Life Sciences Second Quarter 2023 Financial Results Scheduled for August 3, 2023 (GlobeNewswire)
Jul-06-23 08:40AM	Wave Life Sciences (NASDAQ:WVE) shareholders have endured a 90% loss from investing in the stock five years ago (Simply Wall St.)
Jun-26-23 08:30AM	Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes (GlobeNewswire)
Jun-19-23 08:00AM	Top Penny Stocks for Q3 2023 (Investopedia)
May-23-23 07:30AM	Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia (GlobeNewswire)
May-16-23 08:30AM	Wave Life Sciences to Highlight Leading RNA Editing Capability and Multimodal Discovery and Development Platform at ASGCT 26th Annual Meeting (GlobeNewswire) -7.94%
May-08-23 06:03AM	The Consensus EPS Estimates For Wave Life Sciences Ltd. (NASDAQ:WVE) Just Fell Dramatically (Simply Wall St.)
06:19AM	Loading…
May-05-23 06:19AM	Wave Life Sciences First Quarter 2023 Earnings: Misses Expectations (Simply Wall St.) +9.32%
May-03-23 08:55AM	Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:49AM	Wave Life Sciences: Q1 Earnings Snapshot (AP Finance)
07:30AM	Wave Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Apr-26-23 08:30AM	Wave Life Sciences First Quarter 2023 Financial Results Scheduled for May 3, 2023 (GlobeNewswire)
Apr-20-23 08:30AM	Wave Life Sciences Announces Nucleic Acids Research Publication Highlighting Potential Best-in-Class siRNAs Designed with Wave Platform Chemistry (GlobeNewswire)
Mar-29-23 08:54AM	Can Wave Life Sciences (NASDAQ:WVE) Afford To Invest In Growth? (Simply Wall St.) +8.48%
08:00AM	Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days (GlobeNewswire)
Mar-24-23 07:36AM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2022 Earnings Call Transcript (Insider Monkey) -5.04%
Mar-22-23 08:45AM	Wave Life Sciences (WVE) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -10.38%
07:30AM	Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Mar-02-23 08:30AM	Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023 (GlobeNewswire)
Feb-14-23 12:00PM	Wave Life Sciences (WVE) Upgraded to Buy: Here's What You Should Know (Zacks)
09:35AM	After Plunging -23.26% in 4 Weeks, Here's Why the Trend Might Reverse for Wave Life Sciences (WVE) (Zacks)
Feb-09-23 04:05PM	Wave Life Sciences to Present at the 2023 Virtual SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-25-23 06:06AM	Wave Life Sciences (NASDAQ:WVE) shareholders have earned a 115% return over the last year (Simply Wall St.)
Jan-13-23 07:26AM	Morphic Holding, Inc. (MORF) Surges 18.7%: Is This an Indication of Further Gains? (Zacks)
Jan-03-23 05:40AM	The Zacks Analyst Blog Highlights AVEO Pharmaceuticals, Cabaletta Bio, Verona Pharma and Wave Life Sciences (Zacks) -11.43%
Dec-30-22 12:00PM	All You Need to Know About Wave Life Sciences (WVE) Rating Upgrade to Buy (Zacks)
09:03AM	4 Drug Stocks That More Than Doubled This Year (Zacks)
Dec-19-22 01:04PM	Wave Life Sciences Touts Encouraging Data From Duchenne Muscular Dystrophy Study (Benzinga)
07:37AM	Wave Life Sciences Provides Positive Update on Proof-of-Concept Study for WVE-N531 in Duchenne Muscular Dystrophy (GlobeNewswire)
Dec-15-22 09:07AM	Wave Life Sciences (WVE) Up 26% on Collaboration With GSK (Zacks) -10.47%
06:11AM	Wave Life Sciences Ltd.'s (NASDAQ:WVE) Intrinsic Value Is Potentially 52% Above Its Share Price (Simply Wall St.)
Dec-13-22 11:27AM	Wave, GSK enter strategic collaboration that could be worth up to $3.3 billion in milestone payments (MarketWatch) +32.69%
09:51AM	Wave Life Sciences Shares Move Higher On Therapeutic Pact With GSK Targeting Genetic Disorders (Benzinga)
07:30AM	Wave Life Sciences and GSK Announce Collaboration to Drive Discovery and Development of Oligonucleotide Therapeutics Focusing on Novel Genetic Targets (GlobeNewswire)
Nov-10-22 08:45AM	Wave Life Sciences (WVE) Reports Q3 Loss, Misses Revenue Estimates (Zacks) +5.84%
07:30AM	Wave Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Nov-09-22 08:30AM	Wave Life Sciences to Present at the Stifel 2022 Healthcare Conference (GlobeNewswire) -14.90%
Nov-03-22 08:30AM	Wave Life Sciences to Webcast Conference Call of Third Quarter 2022 Financial Results on November 10, 2022 (GlobeNewswire)
Oct-17-22 11:27AM	Wave Life Sciences (WVE) Soars 13.8%: Is Further Upside Left in the Stock? (Zacks) -11.73%
Oct-12-22 02:35PM	Atlas-backed gene-silencing startup winds down (American City Business Journals)
01:35PM	Is Wave Life Sciences (NASDAQ:WVE) In A Good Position To Deliver On Growth Plans? (Simply Wall St.)
Oct-03-22 08:30AM	Wave Life Sciences to Highlight Advancements from PRISM Platform at Upcoming Scientific Congresses (GlobeNewswire)
Sep-28-22 01:30PM	Wave Life Sciences Highlights Therapeutic Potential for WVE-006 for Alpha-1 Antitrypsin Deficiency and Progress Bringing RNA Editing to the Clinic During Analyst and Investor Event (GlobeNewswire)
Sep-27-22 08:30AM	Wave Life Sciences to Present at Chardans 6th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-21-22 11:39AM	Wave Therapeutics (WVE) Up on Update From Huntington's Study (Zacks)
Sep-20-22 12:44PM	Wave Life Sciences Touts Positive Update From Its Lead Huntington's Program (Benzinga) +8.26%
07:30AM	Wave Life Sciences Announces Positive Update from Phase 1b/2a SELECT-HD Trial with Initial Results Indicating Allele-Selective Target Engagement with WVE-003 in Huntingtons Disease (GlobeNewswire)
Sep-16-22 08:30AM	Wave Life Sciences to Host Analyst and Investor Virtual Event, Towards the Clinic: Spotlight on RNA Editing for AATD, on September 28, 2022 (GlobeNewswire)
Aug-13-22 08:12AM	News Flash: 7 Analysts Think Wave Life Sciences Ltd. (NASDAQ:WVE) Earnings Are Under Threat (Simply Wall St.)
Aug-11-22 03:18PM	Why Wave Life Sciences Was Zooming Higher Today (Motley Fool) +16.86%
08:45AM	Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:30AM	Wave Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Aug-03-22 06:15PM	Mirati (MRTX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-28-22 08:30AM	Wave Life Sciences to Webcast Conference Call of Second Quarter 2022 Financial Results on August 11, 2022 (GlobeNewswire) -5.59%
Jul-20-22 10:05AM	Investors three-year losses grow to 82% as the stock sheds US$39m this past week (Simply Wall St.)
Jun-20-22 09:54AM	Here's What Wave Life Sciences Ltd.'s (NASDAQ:WVE) Shareholder Ownership Structure Looks Like (Simply Wall St.)
Jun-14-22 09:00AM	Wave Life Sciences Announces Pricing of $70.0 Million Underwritten Offering (GlobeNewswire)
May-25-22 08:30AM	Wave Life Sciences to Present at the 2022 Jefferies Healthcare Conference (GlobeNewswire)
May-13-22 02:51PM	Ahead Of Upcoming Data On Three Programs, Analysts Remain On Sidelines For Wave Life Sciences (Benzinga)
May-12-22 08:45AM	Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -12.24%
07:30AM	Wave Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
May-10-22 08:30AM	Wave Life Sciences to Present at Upcoming Investor Conferences (GlobeNewswire) +7.28%
May-05-22 01:21PM	Here's Why We're Watching Wave Life Sciences' (NASDAQ:WVE) Cash Burn Situation (Simply Wall St.) -9.79%
08:30AM	Wave Life Sciences to Webcast Conference Call of First Quarter 2022 Financial Results on May 12, 2022 (GlobeNewswire)
Apr-25-22 08:30AM	Wave Life Sciences Announces Publication of Foundational Preclinical Data Supporting Development of WVE-004 for C9orf72-associated ALS and FTD (GlobeNewswire) +5.76%
Apr-19-22 08:30AM	Wave Life Sciences to Present at Chardans 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit (GlobeNewswire)
Apr-04-22 12:16PM	Wave Life Sciences Jump As Low Doses of WVE-004 Lowers Disease Biomarker In Neurological Indications (Benzinga) +14.29%
07:30AM	Wave Life Sciences Announces Positive Update to Ongoing Phase 1b/2a FOCUS-C9 Study Driven by Potent, Durable Reductions of Poly(GP) with Low, Single Doses of WVE-004 (GlobeNewswire)
Mar-21-22 08:30AM	Wave Life Sciences to Present at Stifel 2022 CNS Days (GlobeNewswire)
07:05AM	Athira Pharma Announces Appointment of Dr. Michael A. Panzara to its Board of Directors (GlobeNewswire)
Mar-15-22 08:30AM	Wave Life Sciences to Highlight RNA Base Editing Modality and Alpha-1 Antitrypsin Deficiency Program at Upcoming Scientific and Industry Meetings (GlobeNewswire)
Mar-07-22 11:14AM	Wave Life Sciences Announces Nature Biotechnology Publication Highlighting First RNA Base Editing in Non-Human Primates Using an Endogenous Enzyme (GlobeNewswire) -9.91%
Mar-03-22 08:45AM	Wave Life Sciences (WVE) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
07:30AM	Wave Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (GlobeNewswire)
Mar-01-22 10:25AM	Albireo Pharma (ALBO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
Feb-24-22 08:30AM	Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022 (GlobeNewswire) -7.85%
Feb-15-22 05:55PM	Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Tops Revenue Estimates (Zacks)

Wave Life Sciences Ltd. is a clinical-stage genetic medicines company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, optimization, and production of novel stereopure oligonucleotides. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Moran Kyle	Chief Financial Officer	Aug 23	Sale	4.75	37,062	176,119	46,120	Aug 23 09:15 PM
BOLNO PAUL	President and CEO	Feb 16	Sale	4.04	29,400	118,776	407,425	Feb 17 08:10 PM
Francis Chris	See Remarks	Feb 16	Sale	4.03	10,258	41,340	79,714	Feb 17 08:05 PM
Vargeese Chandra	See Remarks	Feb 16	Sale	4.03	10,249	41,303	106,624	Feb 17 08:15 PM
Moran Kyle	Chief Financial Officer	Feb 16	Sale	4.04	9,729	39,305	79,751	Feb 17 08:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

WVE

Wave Life Sciences Ltd.

Upgrade your FINVIZ experience